Similarly, Carnitine Palmitoyltransferase 1A (CPT1A), a key enzyme in carnitine-dependent transport across the mitochondrial inner membrane of FAs, was found to be overexpressed in bone marrow samples from AML patients with poor prognosis compared to those with normal bone marrow [6]. This evidence concerns the gene CPT1A and acute myeloid leukemia.